AI Article Synopsis
- The study investigated how age affects the health outcomes and complications in patients treated with GreenLight laser prostatectomy for benign prostatic hyperplasia (BPH).
- Data was collected from 168 male patients, split into non-octogenarian and octogenarian groups, with findings showing that octogenarians had higher ASA scores indicating more health risks, yet surgery results were comparable between age groups.
- The results suggest that GreenLight laser prostatectomy is a safe and effective option for treating BPH in both older and younger patients, providing similar functional outcomes and quality of life improvements.
Article Abstract
Introduction: We evaluated the impact of age on perioperative morbidity and clinical outcomes in patients undergoing GreenLight laser prostatectomy for benign prostatic hyperplasia (BPH).
Methods: We conducted a retrospective study of prospectively collected data from individuals who underwent GreenLight laser prostatectomy from May 2018 to July 2022. Patient demographics and outcome measures were recorded, including indications for the procedure and American Society of Anesthesiology (ASA) scores. All patients had postoperative followup visits at one, three, six, and 12 months. Our evaluation included the International Prostate Symptom Score (IPSS ), quality of life (QoL) assessment, maximum urinary flow rate (Qmax), postvoid residual volume (PVR), and catheter-free status.
Results: One-hundred-sixty-eight males who underwent GreenLight laser prostatectomy were included. The non-octogenarian group consisted of 111 patients and the octogenarian group comprised 57 individuals. Based on ASA scores, most octogenarians were deemed high-risk (ASA III: 91.2%), while over half of non-octogenarians were lower-risk (ASA II: 53.2%) (p<0.001). Intraoperative parameters, including operative time, vaporization time, lasing time, and energy did not differ significantly between groups. There was no difference in the proportion of intraoperative complications between non-octogenarians and octogenarians (0.9% vs. 3.5%). Postoperative complications were not statistically significant between the two groups (p=0.608). There was also no observed difference in the proportion of patients requiring readmission (p=0.226) or retreatment (p=1.0).
Conclusions: GreenLight laser prostatectomy is a safe and effective treatment for BPH regardless of age. It provides similar surgical and functional outcomes as younger men while maintaining the QoL of octogenarians.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10954284 | PMC |
| http://dx.doi.org/10.5489/cuaj.8482 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser Prostatectomy.
Clin Interv Aging
December 2024
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan City, Taiwan.
Objective: To investigate the impact of body mass index (BMI) on preoperative characteristics, lower urinary tract symptoms (LUTS), intraoperative variables, surgical outcomes and postoperative complications.
Methods: This is a retrospective observational study including 891 benign prostate hyperplasia (BPH) patients who underwent GreenLight Laser photoselective vaporization of the prostate (PVP) between 2014 and 2020. Clinical characteristics, uroflowmetry parameters, and surgery related parameters were extracted from electronic health records.
Comparative efficacy and safety of 180 W XPS . 120 W HPS GreenLight laser therapy for benign prostatic hyperplasia: a systematic review and meta-analysis.
PeerJ
December 2024
Department of Paediatric Surgery, Nanchong Central Hospital, Nanchong, Sichuan, China.
Article Synopsis
- - The study compares the effectiveness of 120 W HPS and 180 W XPS GreenLight laser systems for treating benign prostatic hyperplasia (BPH), revealing that the 180 W system has better operational efficiency and shorter catheterization times.
- - Eight studies were analyzed, showing that while both systems had similar functional outcomes regarding prostate symptoms and urinary flow, the 180 W system resulted in improved quality of life and lower rates of complications.
- - The findings suggest that the 180 W XPS laser is a more efficient and safer option for treating BPH, especially in larger prostates, and encourages further randomized trials to verify these results and investigate long-term effects.
A 72-year-old high-risk male presented to our hospital with severe bladder outlet obstruction (BOO) caused by an enlarged prostate with a volume exceeding 130 cc. Subsequently, the patient successfully underwent GreenLight laser (Boston Scientific, Marlborough, MA, USA) photoselective vaporization of the prostate (PVP). The patient had been unsuitable for conventional surgical modalities such as transurethral resection of the prostate (TURP) or open prostatectomy due to multiple pre-existing comorbidities, including coronary artery disease (CAD), atrial fibrillation (AF), and concurrent use of antiplatelet therapy.
View Article and Find Full Text PDFObjective Our study was designed to evaluate the postoperative urinary retention (UR) and success rate of the GreenLight Laser (Boston Scientific, Marlborough, MA, USA) photoselective vaporization of the prostate (GLL.PVP) procedure for Benign Prostatic Hyperplasia (BPH) patients, both with and without high-risk factors. Methodology We conducted a retrospective follow-up study of postoperative patients who underwent GLL.
View Article and Find Full Text PDFSearch trends in the treatment for benign prostatic hyperplasia: A twenty-year analysis.
Asian J Urol
October 2024
Department of Urology, Weill Cornell Medicine, New York, NY, USA.
Objective: Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recent years. We aimed to determine what types of events may influence patient search habits related to surgical BPH treatments.
Methods: Google Trends was used to determine the frequency of searches for different minimally invasive and prostatic ablative treatments for BPH in the United States.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!